Most Read Articles
Roshini Claire Anthony, 3 days ago

Patients with mild hypertension who are at low risk for cardiovascular disease (CVD) do not appear to derive mortality or CVD benefit from antihypertensive treatments, raising questions on the need for treatment in this population, according to a recent study from England.

Pearl Toh, 6 days ago
A personalized computerized neurofeedback intervention for training attention and memory shows potential in cognitive training for healthy elderly men, who improved in cognitive performance after the training, although no significant improvements were seen in the overall study population.
4 days ago
The simple Atrial fibrillation (AF) Better Care (ABC) pathway holistically updates the integrated care for AF patients and helps reduce the risk of adverse outcomes such as all-cause mortality, stroke/major bleeding/cardiovascular death and hospitalization, according to a study.
Yesterday
Type 1 diabetes impairs cognitive functioning in children, and this effect is exacerbated by extreme glycaemic levels, according to a recent meta-analysis.

BMD loss similar between CAB and GnRH agonist monotherapy

14 Mar 2017

Asian prostate cancer patients may show a significant reduction in bone mineral density (BMD) 12 months after androgen deprivation therapy (ADT) with no difference between those on continuous combined androgen block (CAB) and those on gonadotropin-releasing hormone (GnRH) agonist monotherapy, a new study shows.

A total of 312 patients with prostate cancer were included in the study. Participants were at least 50 years of age and were scheduled to receive ADT either with CAB (n=70) or with GnRH agonist monotherapy (n=242).

Dual energy x-ray absorptiometry was used to measure BMD, while the Fracture Risk Assessment Tool (FRAX) was used to measure the 10-year probability of getting major fractures.

After 12 months of ADT treatment, the proportion of individuals with osteopenia or osteoporosis slightly increased, but the change did not significantly differ between the two groups (p=0.3688). Moreover, the mean BMD of the L-spine decreased by -0.04 in the CAB group (p<0.0009) and by -0.05 in the GnRH group (p<0.001).

The FRAX scores also showed that after 12 months, the mean 10-year probability of major fractures was 4.96 percent for the CAB group and 5.85 percent for the GnRH group. These were not significantly different from the baseline values and between the groups (p>0.05).

On the other hand, the 10-year mean probability of hip fractures was 2.41 percent for the GnRH group and 1.69 percent for the CAB group. The probability for the CAB group showed a significant increase from baseline (p=0.0231), but the difference between the groups was not significant (p=0.5531).

Finally, analysis showed that the treatment group was not associated with the changes in BMD (p>0.05).

The finding that neither CAB nor GnRH agonist monotherapy bear any clinical significance on the risk of fractures thus imply that the ADT-induced bone loss does not lead to bone-related diseases.

Editor's Recommendations
Most Read Articles
Roshini Claire Anthony, 3 days ago

Patients with mild hypertension who are at low risk for cardiovascular disease (CVD) do not appear to derive mortality or CVD benefit from antihypertensive treatments, raising questions on the need for treatment in this population, according to a recent study from England.

Pearl Toh, 6 days ago
A personalized computerized neurofeedback intervention for training attention and memory shows potential in cognitive training for healthy elderly men, who improved in cognitive performance after the training, although no significant improvements were seen in the overall study population.
4 days ago
The simple Atrial fibrillation (AF) Better Care (ABC) pathway holistically updates the integrated care for AF patients and helps reduce the risk of adverse outcomes such as all-cause mortality, stroke/major bleeding/cardiovascular death and hospitalization, according to a study.
Yesterday
Type 1 diabetes impairs cognitive functioning in children, and this effect is exacerbated by extreme glycaemic levels, according to a recent meta-analysis.